Scopolamine Patch, Extended Release
Product Images NDC 42858-150

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 42858-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Scopolamine 01)

Chemical structure diagram of scopolamine, the active ingredient. The diagram shows the molecular arrangement including nitrogen, oxygen, carbon atoms, and functional groups characteristic of scopolamine.*

FDA Label Image

Image (Scopolamine 02)

An illustration diagram of a transdermal patch showing five labeled layers from top to bottom: Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner. It depicts the structural components of the patch delivery system.*

FDA Label Image

Figure 1 (Scopolamine 03)

An illustration showing a Scopolamine extended-release transdermal patch with labeled components including a clear disposable release liner, a metallic adhesive surface, and a tan backing membrane imprinted with 'Scopolamine 1mg/3 days'.*

FDA Label Image

Figure 2 (Scopolamine 04)

An instructional diagram labeled 'Figure 2' illustrating a piece of paper with text and a dotted line near the top edge, accompanied by a directive to 'cut along dotted line.' The image likely serves as a usage or preparation guide related to the product.*

FDA Label Image

Figure 3 (Scopolamine 05)

An instructional illustration showing hands peeling apart a protective layer from a scopolamine transdermal patch, preparing it for application. The image emphasizes careful handling to remove the backing before use.*

FDA Label Image

Figure 4 (Scopolamine 06)

Illustration showing hands peeling a scopolamine transdermal patch from its clear, disposable release liner. The patch is described as having a tan-colored imprinted transdermal system and a metallic adhesive surface.*

FDA Label Image

Figure 5 (Scopolamine 07)

Illustration showing the placement of a scopolamine transdermal patch behind the ear on the side of the head. The patch is described as an imprinted, tan-colored transdermal system.*

FDA Label Image

Principal Display Panel (4 Patch Pouch Box)

Carton packaging for Scopolamine Transdermal System 1 mg/3 days. The label indicates it is a transdermal patch delivering approximately 1 mg over three days. The multipack contains 4 transdermal systems. Marketed by Rhodes Pharmaceuticals LLC and manufactured by ITS Lohmann Therapy-Systems AG. Includes regulatory barcodes and a pictogram of an ear.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.